Back to results
US 8,075,897 B2Granted
Allergen peptide fragments and use thereof
AssigneeAnergis S.A.
InventorsFrancois Spertini, Blaise Corthesy
Life of this patent
Estimating the term…
Abstract
The present invention relates generally to in vivo methods and compositions designed for allergen specific immunotherapy. The compositions include contiguous overlapping peptide fragments which together form an entire amino acid sequence of an allergen.
Claims1
A composition comprising a plurality of contiguous overlapping peptide fragments 30 to 90 amino acids in length which peptide fragments consist of peptides within SEQ ID NOs:
- 5 and 6 which peptide fragments together comprise the entire amino acid sequence of a birch pollen allergen (SEQ ID NO:
- 7), wherein said fragments are capable of inducing a T cell response in patients who are hypersensitive to said allergen.
Dependencies are inferred from the claim text.